Overexpression of miR-709a-5pincreases oxidative stress and the levels of lipogenic enzymes, whichin turn contribute to DN by modulating the suppression of its target NFE2L2. In diabetic kidney disease, miR-709a-5p inhibitorsmay have a therapeutic effect. Here, NFE2L2 is linked to diabetic kidney disease.